QR код

Vedolizumab for stricturing Crohn’s disease of the terminal ileum – an international multicenter cohort study

Abstract Objective Crohn’s disease (CD) frequently progresses to stricturing complications. Anti-stricture therapies are lacking, and anti-inflammatory therapies are hence the mainstay of medical treatment. However, data on the efficacy of vedolizumab in stricturing CD are not available. We therefor...

Повний опис

Збережено в:
Автори: Sara El Ouali, Mark E. Baker, Cathy Lu, Alexandra Medellin, David H. Bruining, Joel G. Fletcher, Akitoshi Inoue, Miguel Regueiro, Ronald K. Ottichilo, Shayla Schoenoff, Ryan Rosentreter, James Bena, Taha Qazi, Stefan D. Holubar, Samantha Gauriloff, Namita S. Gandhi, Katherine Falloon, Joseph Sleiman, Benjamin L. Cohen, Idan Goren, Numan Balci, Florian Rieder, the Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium
Формат: Artigo
Мова:Inglês
Опубліковано: BMC 2026-05-01
Серія:BMC Gastroenterology
Предмети:
Crohn’s disease
Surgery
Dilation
Stricture
Intervention
Vedolizumab
Онлайн доступ:https://doi.org/10.1186/s12876-026-04815-4
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси